Bioventus Inc (BVS) FY2025Q3 Earning Prediction

11/04 05:00:00

Pre-Market

Bioventus Inc (BVS) is set to release its earnings performance on 11/04 05:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of 138.19M and an earnings per share (EPS) of for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueBEAT

138.19M

138.65M

+0.34%

EPS-

0.15

AI Summary

Slide

Attend Webcast

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

BVS Transcript

Bioventus Inc. (BVS) Q3 2025 Earnings Call Transcript

Positive11-4

The earnings call highlighted strong financial performance with 8% organic revenue growth, 13% EBITDA increase, and a 200% rise in EPS. Despite tariff impacts, gross margins remained robust. The Q&A section revealed optimism about product lines and market expansion, with positive feedback on new offerings. The company maintained guidance, indicating confidence. However, lack of specific future guidance slightly tempers the outlook. Overall, the financial health and strategic initiatives suggest a positive stock price movement.

Bioventus Inc. (BVS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Neutral9-10

Bioventus Inc. (BVS) Q2 2025 Earnings Call Transcript

Positive8-7

The earnings call summary reveals strong financial performance, with significant adjusted EPS and EBITDA margin growth, and positive revenue trends across several segments. The Q&A section highlights continued growth in key areas and strategic investments, despite competitive challenges and tariff impacts. The company's guidance remains optimistic, with expectations of accelerated growth and increased R&D investment. These factors, combined with disciplined cost management and a focus on high-growth opportunities, suggest a positive outlook for the stock price over the next two weeks.

Bioventus Inc. (BVS) Q1 2025 Earnings Call Transcript

Unknown5-6

The earnings call presents a mixed picture. While there is positive guidance for 2025, the current quarter showed a revenue decline and cash outflow. The Q&A highlighted some uncertainties, such as competition and unclear management responses on tariffs. The positive aspects include strong EPS growth and leverage reduction plans. However, the stock price is unlikely to move significantly due to the mixed signals and lack of clear market cap information.

BVS Slides

Bioventus Q1 2025 slides: 5% organic growth despite revenue decline, maintains guidance

2025-05-06

Bioventus Q2 2025 slides: 6% organic growth despite revenue dip, FDA clearance boosts outlook

2025-08-06

Bioventus Q3 2025 slides: 8% organic growth with margins expanding despite flat revenue

2025-11-04

BVS Report

Frequently Asked Questions

What is the Bioventus Inc FY2025Q3 Earnings Release Date and Time?

Bioventus Inc (BVS) is scheduled to release its FY2025Q3 earnings report onNov 4, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Bioventus Inc FY2025Q3 Revenue and EPS?

Analysts' consensus predicts 138.19M in revenue and an EPS of 0.00 for Bioventus Inc's FY2025Q3.

What Does Intellectia's AI Predict for Bioventus Inc FY2025Q3 Earnings?

Intellectia's exclusive AI algorithms forecast a forBioventus Inc's FY2025Q3 earnings, with a prediction date of Nov 4, 2025. Bioventus Inc

How Can I Use This Earnings Prediction to Trade BVS Stock?

Leverage Intellectia's AI forecast to position trades ahead of theNov 4, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Bioventus Inc FY2025Q3?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!